- Home
- RZLT
RZLT
Rezolute Inc. (NV)
as of 12-17-2025 3:54pm EST
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.
| Founded: | 2010 | Country: | United States |
| Employees: | 71 | City: | REDWOOD CITY |
| Market Cap: | 187.3M | IPO Year: | N/A |
| Target Price: | $12.33 | AVG Volume (30 days): | 11.4M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.92 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.07 - $11.46 | Next Earning Date: | 11-06-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Rezolute Inc. (NV) (RZLT)
CFO
Avg Cost/Share
$1.78
Shares
45,000
Total Value
$79,577.50
Owned After
415,900
CEO
Avg Cost/Share
$1.59
Shares
32,000
Total Value
$50,880.00
Owned After
641,119
SEC Form 4
Chief Commercial Officer
Avg Cost/Share
$1.61
Shares
12,100
Total Value
$19,598.80
Owned After
71,442
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Evans Daron | RZLT | CFO | Dec 15, 2025 | Buy | $1.78 | 45,000 | $79,577.50 | 415,900 | |
| Elam Nevan C | RZLT | CEO | Dec 15, 2025 | Buy | $1.59 | 32,000 | $50,880.00 | 641,119 | |
| Karnawat Sunil Ratilal | RZLT | Chief Commercial Officer | Dec 15, 2025 | Buy | $1.61 | 12,100 | $19,598.80 | 71,442 |
Compare RZLT vs Leading Stocks
See how RZLT stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "RZLT Rezolute Inc. (NV) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.